Genelex Blog Is Big Data Clinically Significant?
Genelex Blog YouScript CEO to speak at Arrowhead’s Precision Medicine Conference On October 12th and 13th, Arrowhead Publishing is hosting their 8th Annual Personalized & Precision Medicine Conference in San Francisco, California. Any conference dealing with precision and personalized
Genelex Blog YouScript Wins Cambia Grove/Aging2.0 Satellite Contest On June 22, 2016, CEO Kristine Ashcraft presented YouScript for the Seattle Aging 2.0 satellite contest at the Cambia Grove office in Seattle, Washington. Aging 2.0, a national organization promoting innovation for an aging
Genelex Blog YouScript: A Unique, State of the Art, Healthcare Solution Hear what Barry Bittman, MD has to say about YouScript. A well-respected member of the medical community, Dr. Bittman is a neurologist, author, international speaker, researcher and inventor. As CEO of the Institute for
Genelex Blog YouScript Precision Prescribing: A Veteran’s Story Did you know the VA now covers Genelex testing for veterans? A recently approved contract is making pharmacogenetic testing accessible to clinicians in the Veterans Administration, so their patients can benefit from precision
Genelex Blog I Received My Test Results…Now What? I Received My YouScript Results, Now What? Here at YouScript we understand you may have questions about deciphering your results. Pharmacogenetic analysis isn’t something that every doctor is currently familiar with, but if you’ve completed
Genelex Blog Risk Stratification…What You Don’t Know Will Hurt You The care management team is perhaps one of the largest sources of investment for ACOs or any other organization transitioning to a value-based payment model. Therefore, it is critical that an organization use every piece of
Genelex Blog Population Health: YouScript’s Genetic Risk Analysis Tool We’ve recently updated our Risk Analysis tool in YouScript to make it more useful for you! On the left side of the screen, you will see the Genetic Risk Stratification graph. This graph shows the likelihood of CYP